Systems, devices, and/or methods for managing transdermal patches
View Patent ↗Certain exemplary embodiments can provide a system, machine, device, manufacture, circuit, composition of matter, and/or user interface adapted for and/or resulting from, and/or a method and/or machine-readable medium comprising machine-implementable instructions for, activities that can comprise and/or relate to, controlling delivery of a transdermally-delivered medication, certain embodiments including a flux controller.
1. A system for manually controlling delivery of a transdermally-delivered medication, comprising:
a transdermal patch defining a delivery face, the transdermal patch configured to deliver medication to the skin of a patient;
a flux controller that is configured for the patient to selectively manually control a delivery flowrate of the medication to the skin of the patient from the delivery face of the transdermal patch; and
a impermeable envelope configured to sealingly contain the patch and the flux controller;
wherein:
the flux controller defines a selectively patient-sizable impermeable portion having a plurality of apertures therethrough;
each of the plurality of apertures is sized to allow the medication to permeate therethrough from the patch to the skin;
the plurality of apertures are configured to define a predetermined reduction in a labeled medication flowrate for the patch;
the plurality of apertures are dispersed in a pattern;
the flux controller is non-destructively removeably adhered to a backing;
the flux controller is configured to be non-destructively manually removed by the patient from the backing prior to being paired by the patient with the patch;
the patch is configured to be attached to the skin;
the flux controller is configured to be attached to the skin;
the flux controller is configured as a semi-permeable tape having adhesive attached thereto;
the semi-permeable tape has a skin-adhering adhesive attached thereto; and
the semi-permeable tape has a patch-adhering adhesive attached thereto.
2. A system for manually controlling delivery of a transdermally-delivered medication, comprising:
a transdermal patch defining a delivery face, the transdermal patch configured to deliver medication to the skin of a patient;
a flux controller that is configured for the patient to selectively manually control a delivery flowrate of the medication to the skin of the patient from the delivery face of the transdermal patch; and
wherein:
the flux controller defines a selectively patient-sizable impermeable portion having a plurality of apertures therethrough;
each of the plurality of apertures is sized to allow the medication to permeate therethrough from the patch to the skin; and
the plurality of apertures are configured to define a predetermined reduction in a labeled medication flowrate for the patch.
3. The system of claim 2 , wherein:
the plurality of apertures are dispersed in a pattern.
4. The system of claim 2 , wherein:
the plurality of apertures are dispersed in a random pattern.
5. The system of claim 2 , wherein:
the plurality of apertures are dispersed in a predetermined array pattern.
6. The system of claim 2 , wherein:
the flux controller is non-destructively removeably adhered to a backing.
7. The system of claim 2 , wherein:
the flux controller is configured to be non-destructively removed, from a backing to which it is adhered, prior to being paired with the patch.
8. The system of claim 2 , wherein:
the patch is configured to be attached to the skin.
9. The system of claim 2 , wherein:
the flux controller is configured to be attached to the skin.
10. The system of claim 2 , wherein:
the flux controller is configured as a semi-permeable tape having adhesive attached thereto.
11. The system of claim 2 , wherein:
the flux controller is configured as a semi-permeable tape having a skin-adhering adhesive attached thereto.
12. The system of claim 2 , wherein:
the flux controller is configured as a semi-permeable tape having a patch-adhering adhesive attached thereto.
13. The system of claim 2 , further comprising:
the patch.
14. The system of claim 2 , further comprising:
a impermeable envelope configured to sealingly contain the patch and the flux controller.
15. A system for manually controlling delivery of a transdermally-delivered medication, comprising:
a flux controller that is configured for a patient to selectively manually control a delivery flowrate of the medication to skin of the patient from a delivery face of a skin-attachable transdermal patch;
wherein:
the flux controller defines patient-adjustably-sizable aperture configured to be manually sized to allow the medication to permeate therethrough from the patch to the skin at a patient-adjustable fraction of a labeled medication flowrate for the patch.